US2013164733A1PendingUtilityA1

Hepatitis-c virus testing

Assignee: SIMMONDS PETERPriority: Nov 21, 1991Filed: Jul 13, 2012Published: Jun 27, 2013
Est. expiryNov 21, 2011(expired)· nominal 20-yr term from priority
C07K 14/005G01N 2333/18C12N 2770/24222A61P 37/04Y10S436/82G01N 33/56983A61P 31/12C07K 2319/00C12Q 1/707G01N 2333/186A61P 31/14C07K 16/118A61K 39/00
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

New styles of hepatitis C virus (HCV), referred to as HCV-3 and HCV-4, have been identified and sequenced. Antigenic regions of HCV-2, HCV-3 and HCV-4 polypeptides have been identified. Immunoassays for HCV and antibodies thereto are described, which allow more complete screening of blood samples for HCV, and allow HCV genotyping.

Claims

exact text as granted — not AI-modified
1 . A method for detecting HCV infection in a mammal, comprising:
 a) obtaining a blood sample from a mammal;   b) isolating RNA from said blood sample;   c) reverse transcribing said RNA into cDNA;   d) performing PCR on said cDNA using sense and antisense primers specific for HCV, wherein said sense and antisense primers are
 SEQ ID NO:42 and SEQ ID NO:40; 
   and,   e) determining whether HCV infection was detected by analyzing the results from said PCR.

Join the waitlist — get patent alerts

Track US2013164733A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.